enterocin A: isolated from Enterococcus faecium; amino acid sequence in first source; do not confuse with enterocin
Enterocin A (EntA) is a low molecular weight, heat-stable, chromosomally encoded class IIa bacteriocin produced by several strains of Enterococcus faecium. It has selective antimicrobial activity against Listeria strains.
Excerpt | Reference |
---|---|
"Enterocin A, because of its remarkable antilisterial activity." | ( Enhancement of the antibacterial activity of an E. faecalis strain by the heterologous expression of enterocin A. Quirasco, M; Serrano-Maldonado, CE, 2018) |
Excerpt | Reference |
---|---|
" Therefore, it may be useful as a safe natural agent in preservation of foods or as a new probiotic strain in food and feed." | ( Safety characterisation and inhibition of fungi and bacteria by a novel multiple enterocin-producing Enterococcus lactis 4CP3 strain. Ben Braïek, O; Cremonesi, P; Ghrairi, T; Hani, K; Morandi, S; Smaoui, S, 2018) |
Excerpt | Reference |
---|---|
" In the present study, the circular bacteriocin enterocin AS-48, applied singly or in combination with phenolic compounds (carvacrol, eugenol, geraniol, and citral) or with 2-nitro-1-propanol (2NPOH), was investigated in the control of a cocktail made from 1 methicillin-sensitive and 1 MRSA strains inoculated on commercial oat and soya drinks." | ( Inactivation of Staphylococcus aureus in Oat and Soya Drinks by Enterocin AS-48 in Combination with Other Antimicrobials. Aguayo, MC; Burgos, MJ; Gálvez, A; López, RL; Pulido, RP, 2015) |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (6.00) | 18.2507 |
2000's | 21 (42.00) | 29.6817 |
2010's | 22 (44.00) | 24.3611 |
2020's | 4 (8.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (1.89%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 52 (98.11%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |